Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CD47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ATP5I - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ACSL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
MPP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPN6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OSBPL11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MSI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIPIN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP48 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GMDS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAM10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LEMD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARPP19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on